Ethereum Treasury Company Propanc Biopharma Reaches Strategic Financing Agreement of Up to $100 Million with Hexstone Capital
-
最新报道：According to Bijie.com, on October 15th, Propanc Biopharma, a biopharmaceutical company utilizing an Ethereum treasury strategy, announced a strategic financing agreement with family office Hexstone Capital for up to $100 million. Propanc CEO James Nathanielsz stated that the financing will accelerate the company's clinical pipeline development and aims to grow the value of its digital asset treasury to $100 million or more within the next 12 months. Hexstone Capital has previously invested in several companies with digital asset treasuries, including BTC, ETH, SOL, DOGE, and other digital assets. Earlier in September, Propanc Biopharma announced plans to acquire $100 million in Ethereum.
下一篇
CoinWorld Morning News
- According to Bijie.com, 1. CZ: The government won't bail out cryptocurrencies, but Binance...
24小时热点
热点专题
413124